Combo Vaccine Fights Hepatitis

Article

PHILADELPHIA, Pa-SmithKline Beecham Pharmaceuticals will being making and distributing a new combination vaccine that fights both hepatitis A and hepatitis B.

The Twinrix vaccine will protect those 18 years of age and older from the threatening viruses. The vaccine has now be recommended for travelers who will be visiting areas with high rates of both diseases, such as Africa, parts of South America, the Middle East, and South and Southeast Asia.

Hepatitis A infection can be contracted by contaminated water or food. Any region of the world without proper sanitation or running water is considered high risk.

Hepatitis B can be spread through infected blood or other body fluids. Healthcare workers are often at high risk for infection.

Both viruses can be asymptomatic. However, hepatitis A can cause fever, malaise, jaundice, liver failure and death. Hepatitis B infections can lead to cirrhosis and liver cancer in a small number of people.

In clinical trials, the Twinrix vaccine was given in a three dose series during a six-month period. It was found to be as safe and effective as the current hepatitis A and hepatitis B vaccines.

Information from www.fda.gov

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content